INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 433m ago
House PTR33m ago
SEC 13F32m ago
Robinhood Chain32m ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
RL
Riesterer Terry L.Vice President and Controller
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$20K
50 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

20
WI
Woods IsaacVice President and Treasurer
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$2,421
6 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

20
Sylebra Capital LlcSee Footnote
PIIMPINJ INC
Open-market sale
SELL$509K
3,167 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

20
RL
Riesterer Terry L.Vice President and Controller
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$4,033
10 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

20
LK
Li Jeffrey KSVP and Secretary
KEYSKeysight Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$790K
3,934 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

19
RS
Robins Harlan SChief Scientific Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$166K
10.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

19
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$169K
5,437 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

19
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$592K
15.8K sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

17
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$5,648
286 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

17
Sylebra Capital LlcSee Footnote
PIIMPINJ INC
Open-market sale
SELL$221K
1,373 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

16
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$69K
1,900 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
DA
Dignan AndyPresident
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
700 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

16
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$38K
95 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

16
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$8,877
22 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

16
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
2,492 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
HJ
Hennessy Daniel JDirector
INVInnventure, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
55.8K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

16
MS
Munshi SanjayChief Operating Officer
NTCTNETSCOUT SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$54K
2,000 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
2,560 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$139K
3,745 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
1,373 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

15
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
2,344 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
1,989 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

15
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$291K
15.5K sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
1,673 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

14
CM
Campbell Lisa MDirector
DTDynatrace, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
253 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
1,200 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,110 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
824 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,075
194 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

11
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
323 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

9
GC
Gibson ChristopherDirector, Chief Executive Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$185K
40.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

8
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
7,767 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

8
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,004 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

8
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
7,766 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

8
MJ
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER
OMCLOMNICELL, INC.
Open-market sale · 10b5-1 plan
SELL$244K
6,106 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

7
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
30.0K sh
Dec 1, 2025Dec 5, 2025
traded Dec 1, 2025
+4dSEC Form 4

Evidence

7
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$819K
45.0K sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

48
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$51K
3,813 sh
Nov 24, 2025Dec 4, 2025
traded Nov 24, 2025
+10dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
994 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
2,378 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

Page 427 of 481
← PrevNext →

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K